313 filings
DEFM14C
QSAM
QSAM Biosciences, Inc.
11 Apr 24
Information related to merger
7:10am
PREM14C
QSAM
QSAM Biosciences, Inc.
1 Apr 24
Preliminary information related to merger
8:32am
10-K
2023 FY
QSAM
QSAM Biosciences, Inc.
Annual report
20 Mar 24
4:51pm
SC 13D/A
Checkmate Strategic Capital 2, LLC
20 Feb 24
QSAM Biosciences / Checkmate Strategic Capital 2 ownership change
5:19pm
5
Checkmate Strategic Capital 2, LLC
20 Feb 24
QSAM Biosciences / Charles Thomas Paschall ownership change
4:51pm
SC 13G/A
youym3qxexyfxtihmbq
20 Feb 24
QSAM Biosciences / Strategic Planning Assets ownership change
6:09am
SC 13G/A
04jvlytnhegg9 1n7
15 Feb 24
QSAM Biosciences / GSB ownership change
9:51pm
4/A
1alb01hnvs9sy
14 Feb 24
QSAM Biosciences / Douglas R Baum ownership change
4:43pm
4/A
t6lxyzfgteujwno40
14 Feb 24
QSAM Biosciences / Christopher M. Nelson ownership change
4:43pm
4/A
hvhjmsg6hmzaaz
14 Feb 24
QSAM Biosciences / Jr. Charles J Link ownership change
4:42pm
4
ln5azlw sexqjnda
13 Feb 24
QSAM Biosciences / Douglas R Baum ownership change
4:00pm
4
qki 3nmey
13 Feb 24
QSAM Biosciences / Christopher M. Nelson ownership change
4:00pm
8-K
9e1lg9jgegkbn3pajxjd
7 Feb 24
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
9:56pm
8-K
hlc9j
16 Jan 24
Other Events
5:08pm
8-K
y0rkze j1k
14 Nov 23
Receives $2 Million Pre-Closing Collaboration and Option Fee
12:00am
8-K
10l2i ypygl80e
29 Sep 23
Unregistered Sales of Equity Securities
4:51pm
8-K
54lqy6oxyxpe e5hry
16 Aug 23
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
4:00pm
4
g3q8rv4izeky g5ox
29 Jun 23
QSAM Biosciences / Adam King ownership change
6:14am